Related Experiment Video

Updated: Jan 1, 2026

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.5K

Staging NAFLD: Diagnostic and Therapeutic Value of TAM Signaling

Francisco Javier Cubero1

  • 1Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, 12 de Octubre Health Research Institute (imas12), Madrid, Spain.

Cellular and Molecular Gastroenterology and Hepatology
|December 28, 2019
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.6K
Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH
07:13

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH

Published on: April 20, 2021

4.4K

Related Experiment Videos

Last Updated: Jan 1, 2026

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.5K
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.6K
Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH
07:13

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH

Published on: April 20, 2021

4.4K

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

452
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
452

Articles linked to this work by shared authors, journal, and citation graph.

Ferroptosis, immune activation and MASH-related HCC.

Gut·2026

Intermittent time-restricted feeding recapitulates the physiological benefits of daily time-restricted feeding in male mice with chronic metabolic disease.

Molecular metabolism·2026

KEAP1-mediated mitochondrial remodeling on stiffness-graded collagen substrates drives hepatocellular carcinoma adaptation.

Biomaterials·2026

Lack of PCK1 in hepatic stellate cells causes liver fibrosis by fueling tricarboxylic acid cycle and increasing glycolysis.

Cell metabolism·2026

Alcohol consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): understanding the gut-liver crosstalk for clinical translation.

Gut microbes·2026

Identification of ACBP as a potential target in ciliopathic obesity through multi-omics network analysis.

Nature communications·2026

Metabolic Dysfunction-Associated Steatohepatitis: Is there evidence for fractured CD4+ T cell tolerance in the immunopathogenesis of MASH?

Cellular and molecular gastroenterology and hepatology·2026

Bcl-xL Promotes Gastric Tumorigenesis via Apoptosis-Independent Wnt/β-Catenin Activation and PPARγ Suppression.

Cellular and molecular gastroenterology and hepatology·2026

Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis.

Cellular and molecular gastroenterology and hepatology·2026

Interleukin13 Ameliorates Hepatocellular Steatosis via Interleukin13Rα1-c-Jun N-Terminal Kinase-FOS-Like Antigen 2 Signaling Pathway.

Cellular and molecular gastroenterology and hepatology·2026

High-fat diet remodels plasma membrane rigidity to potentiate colonocyte stemness in mice.

Cellular and molecular gastroenterology and hepatology·2026

Control of Intestinal Type 3 Immunity by the Unfolded Protein Response Sensor Inositol-Requiring Enzyme 1α in Antigen-Presenting Cells.

Cellular and molecular gastroenterology and hepatology·2026

Nanoparticle-mediated Therapeutic Inventions against Glioblastoma: A Narrative Review on Current Perspectives.

CNS & neurological disorders drug targets·2026

Correction: Satapathy et al. Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain Through BBB. Pharmaceutics 2021, 13, 1183.

Pharmaceutics·2026

Nanorobots and Exosomes: Driving the New Frontier for Bladder Tumors through Non-Coding RNAs.

Oncology research·2026

Lipid nanoparticles as active biointerfaces: From membrane interaction to systemic dysregulation.

Acta pharmaceutica Sinica. B·2026

A Glance at the Recent Nanoparticle-based Therapeutic Approaches Towards Glioblastoma Multiforme.

Current pharmaceutical design·2026

Targeting the Brain: Are Nanodrugs Ready for Clinical Translation in CNS Disorders?

Current drug targets·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us